Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
2,868,956
-
Share change
-
+171,114
-
Total reported value
-
$113,770,000
-
Price per share
-
$39.66
-
Number of holders
-
13
-
Value change
-
+$7,010,708
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q1 2017
As of 31 Mar 2017,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,868,956 shares.
The largest 10 holders included
WCM INVESTMENT MANAGEMENT/CA, Parametric Portfolio Associates LLC, THORNBURG INVESTMENT MANAGEMENT INC, ZEVIN ASSET MANAGEMENT LLC, Boston Common Asset Management, LLC, GARRISON BRADFORD & ASSOCIATES INC, EVERETT HARRIS & CO /CA/, Hemenway Trust Co LLC, PNC Financial Services Group, Inc., and QUADRANT CAPITAL GROUP LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.